谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

RAndomized Clinical Trial of NAfamostat Mesylate, A Potent Transmembrane Protease Serine 2 (TMPRSS2) Inhibitor, in Patients with COVID-19 Pneumonia

Teresa Maria Seccia,Tungalagtamir Shagjaa,Margherita Morpurgo,Brasilina Caroccia,Viola Sanga,Sonia Faoro,Francesca Venturini, Girolama Iadicicco,Sara Lococo,Maria Mazzitelli,Filippo Farnia,Paola Fioretto,Yusuke Kobayashi,Dario Gregori,Gian Paolo Rossi

Journal of Clinical Medicine（2023）

引用 0|浏览4
关键词
nafamostat mesylate,SARS-CoV-2,COVID-19,safety,transmembrane protease serine 2 TMPRSS2,coagulation
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要